JOSEPH FULLER: Open Payments
NPI 1376559351 · ROCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 13 payments from 7 companies in 2025. Trend: 2023 $326 · 2024 $262 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $379 |
| AstraZeneca Pharmaceuticals LP | 4 | $361 |
| Neurocrine BioSciences, Inc. | 1 | $130 |
| Alkermes, Inc. | 1 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Baxter Healthcare | 1 | $61 |
| ABBVIE INC. | 1 | $29 |
Products named: Auvelity, AIRSUPRA, BREZTRI, INGREZZA, ARISTADA, CAPLYTA, Hillrom - Carnation Ambulatory Monitor, UBRELVY.
Industry payments across NH — which companies pay providers there.
